Lau Associates’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$447K Hold
24,686
0.22% 70
2019
Q3
$369K Sell
24,686
-4,000
-14% -$65.1K 0.2% 73
2019
Q2
$688K Hold
28,686
0.33% 60
2019
Q1
$1.07M Sell
28,686
-6,015
-17% -$219K 0.55% 48
2018
Q4
$979K Buy
34,701
+15,515
+81% +$491K 0.54% 48
2018
Q3
$757K Buy
19,186
+6,446
+51% +$282K 0.43% 53
2018
Q2
$565K Hold
12,740
0.39% 50
2018
Q1
$621K Buy
+12,740
New +$637K 0.48% 50
2016
Q4
Sell
-14,659
Closed -$235K 71
2016
Q3
$235K Sell
14,659
-194
-1% -$2.22K 0.24% 66
2016
Q2
$122K Hold
14,853
0.13% 70
2016
Q1
$104K Hold
14,853
0.11% 69
2015
Q4
$80K Sell
14,853
-1,131
-7% -$7.23K 0.09% 68
2015
Q3
$103K Buy
+15,984
New +$167K 0.12% 65

Other funds holding CC

Lau Associates's CC Position: Q4 2019 in Review

Lau Associates held its Chemours (CC) position steady in Q4 2019 at 24,686 shares worth $447K. The position accounts for 0.22% of the portfolio, ranked #70.

Lau Associates first reported a position in CC in Q3 2015 and has held it in 13 quarters since. The position peaked at $1.07M in Q1 2019. 439 funds tracked by Wall St. Rank hold CC as of Q4 2019.

  • Lau Associates held 24,686 shares of Chemours worth $447K as of Q4 2019.
  • Lau Associates left its Chemours share count unchanged in Q4 2019.
  • Chemours made up 0.22% of Lau Associates's portfolio in Q4 2019, its #70 holding.
  • Lau Associates first reported a position in Chemours in Q3 2015 and has held it in 13 quarters since.
  • Lau Associates's Chemours position peaked at $1.07M in Q1 2019.
  • 439 funds tracked by Wall St. Rank held Chemours as of Q4 2019.

Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.